CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Thousands	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Cash flows from operating activities:
Net loss	$ (130,870)	$ (70,795)
Adjustments to reconcile net loss to cash flows used in operating activities:
Depreciation of property and equipment	1,540	464
Amortization of debt discount and premium and discount on available-for-sale marketable securities	(5,953)	(856)
Provision for excess and obsolete inventory	0	693
Loss on extinguishment of debt	0	1,347
Stock-based compensation	36,740	12,057
Deferred income tax	90	83
Changes in operating assets and liabilities:
Accounts receivable and other current assets	(244)	14,432
Other assets	(5,832)	0
Inventory	1,600	(1,553)
Accounts payable and accrued expenses	5,731	1,519
Right-of-use assets and operating lease liabilities	1,618	(39)
Deferred revenue	(30,646)	44,523
Net cash (used in) provided by operating activities	(126,226)	1,875
Cash flows from investing activities:
Purchases of marketable securities	(398,303)	(55,116)
Sales and maturities of marketable securities	183,000	55,284
Purchases of property and equipment	(4,052)	(3,483)
Net cash (used in) provided by investing activities	(219,355)	(3,315)
Cash flows from financing activities:
Proceeds from issuance of stock	163,314	226,174
Payment of equity issue costs	(672)	(451)
Payment of long-term debt	0	(30,000)
Payment of extinguishment of debt costs	0	(1,350)
Borrowings under revolving facility	0	5,300
Repayment under revolving facility	0	(15,775)
Net settlement of stock units to satisfy statutory tax withholding	(4,512)	(169)
Proceeds from exercise of stock options and employee stock purchase plan	5,997	3,377
Principal payments on finance lease obligations	(105)	(36)
Net cash provided by (used in) financing activities	164,022	187,070
Net (decrease) increase in cash, cash equivalents and restricted cash	(181,559)	185,630
Cash, cash equivalents and restricted cash at beginning of period	281,413	95,783
Cash, cash equivalents and restricted cash at end of period	99,854	281,413
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Cash and cash equivalents	99,704	281,263
Restricted cash	150	150
Total cash, cash equivalents and restricted cash at end of period	99,854	281,413
Supplemental cash flow information:
Cash interest paid	0	1,405
Supplemental disclosure of non-cash investing and financing activities:
Lease liability arising from obtaining right-of-use assets	17,544	0
Stock issuance costs	$ 311	$ 325